Independent
Tenure on this board
1.2 yrs
Also a director at
Belden Inc (BDC)
Meeting calendar
A · Annual meeting · Wednesday, March 18, 2026
Agilent Technologies Inc
4 nominees · 4 ballot items.
Election of four directors; advisory approval of named executive officer compensation; ratification of PwC as independent registered public accounting firm; approval to amend Certificate of Incorporation to declassify the Board over a three-year period.
Market cap
$37.1B
1Y TSR
+11.8%
Board grade
C
Record date
Jan 21, 2026
Filing
DEF 14A
Meeting concluded · Mar 18, 2026
Follow how the vote landed and what changed on Agilent Technologies Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot4
- 1
Election of four directors to a three-year term
ManagementBoard: FORElect four Class II directors (Judy Gawlik Brown, Sue H. Rataj, George A. Scangos, Ph.D., and Dow R. Wilson) to three-year terms ending in 2029; routine director elections.
- 2
Advisory vote to approve named executive officer compensation (Say-on-Pay
ManagementBoard: FORNon-binding, advisory vote to approve the compensation of named executive officers as disclosed in the proxy statement.
More detail
This management proposal requests an advisory (non-binding) approval of the compensation of the company’s named executive officers as disclosed in the proxy. Management seeks shareholder input to validate its pay-for-performance approach, which emphasizes a high percentage of at-risk compensation (short-term and long-term incentives) tied to revenue, operating margin, EPS and relative TSR metrics. The Compensation Committee has reviewed executive pay practices, engaged an independent consultant, and adjusted incentives for fiscal 2026 to align with strategic priorities and market practice; the committee cites strong shareholder support historically (89% Say-on-Pay in 2025) and ongoing stockholder engagement as rationale. While non-binding, the Company will consider the vote results in future compensation decisions; risks include potential investor dissatisfaction if pay and performance diverge, but management highlights robust governance features (clawbacks, independent committee, stock ownership guidelines, recoupment policy) to mitigate concerns.
- 3
Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm
ManagementBoard: FORRatify the Audit and Finance Committee’s appointment of PwC as the independent registered public accounting firm for fiscal 2026.
- 4
Amendment to Certificate of Incorporation to declassify the Board over a three-year period
ManagementBoard: FORApprove amendment to the Third Amended and Restated Certificate of Incorporation to eliminate the classified board structure over a three‑year transition so that all directors will be elected annually beginning in 2029.
More detail
This management proposal asks stockholders to approve an amendment to the Certificate of Incorporation to phase out the classified board over a three‑year period, responding to a 2025 stockholder proposal and subsequent outreach that showed significant stockholder support for declassification. Management frames this as enhancing accountability by shifting to annual director elections by 2029 while allowing a gradual transition to avoid abrupt board turnover. The Board recommends the amendment citing stockholder feedback, governance evolution, and alignment with market practice; the change also has implications for director removal rules (allowing removal without cause after declassification) and requires a majority of outstanding shares to pass. The proposal is routine but significant in corporate governance, balancing investor preferences for annual elections against benefits of board continuity from classified structures.
Director elections
Nominees on the ballot4
Independent
Tenure on this board
10.8 yrs
Independent
Tenure on this board
11.8 yrs
Also a director at
Voyager Therapeutics Inc (VYGR)
Independent
Tenure on this board
8.3 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 6.5% | 18,381,030 | $2.1B |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.1% | 14,352,682 | $1.6B |
| 3 | STATE STREET CORP | 4.5% | 12,764,632 | $1.5B |
| 4 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3.3% | 9,416,089 | $1.1B |
| 5 | T. Rowe Price Investment Management, Inc. | 3.2% | 8,992,649 | $1.0B |
| 6 | BlackRock, Inc. | 3.2% | 8,943,928 | $1.0B |
| 7 | WELLINGTON MANAGEMENT GROUP LLP | 2.4% | 6,697,485 | $763M |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 6,611,996 | $750M |
| 9 | BlackRock, Inc. | 2.1% | 5,843,670 | $666M |
| 10 | DEUTSCHE BANK AG\ | 1.7% | 4,829,350 | $550M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Agilent Technologies Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Steris PLCSTE
Annual meeting·Jul 31, 2026·$21.3B
Jazz Pharmaceuticals PLCJAZZ
Annual meeting·Jul 23, 2026·$15.5B
Apogee Therapeutics IncAPGE
Special meeting·Aug 11, 2026·$10.1B
Amneal Pharmaceuticals IncAMRX
Special meeting·Jul 31, 2026·$5.7B
Doximity IncDOCS
Annual meeting·Aug 27, 2026·$3.9B
Organon & CoOGN
Special meeting·Jul 23, 2026·$3.6B
Reference
Frequently asked questions
- When is the Agilent Technologies Inc 2026 annual meeting?
- Agilent Technologies Inc (A) holds its 2026 annual shareholder meeting on Wednesday, March 18, 2026.
- What is the record date for the Agilent Technologies Inc 2026 meeting?
- The record date for the Agilent Technologies Inc 2026 meeting is Wednesday, January 21, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Agilent Technologies Inc's 2026 meeting?
- The board is presenting 4 director nominees at the Agilent Technologies Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Agilent Technologies Inc 2026 meeting?
- Shareholders will vote on 4 proposals at the Agilent Technologies Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.